In this video interview, Ananth Kadambi, VP of real-world evidence and modeling solutions at Certara, outlines how FDA’s ...

This episode of the Applied Clinical Trials Brief highlights a new global collaboration between two industry leaders, explores how site networks can address enrollment and retention challenges, and ...

Paul Shawah, EVP, strategy, Veeva Systems and Richard Staub, president, R&D solutions, IQVIA, explain how their partnership is improving efficiency and data management in clinical trials by ...

An interim analysis of the TULIP-SC trial found that weekly subcutaneous delivery of Saphnelo significantly reduced disease ...

Preliminary results from an ongoing Phase IV trial showed that Moderna’s updated 2025-2026 Spikevax vaccine generated a ...

When compared to dulaglutide, Ozempic was associated with a reduced risk of major adverse cardiovascular events such as a heart attack or stroke by 23%. The results of the REACH study were recently ...

The open-label, multicenter AVONELLE-X trial evaluated the long-term safety and tolerability of Vabysmo in 1,036 patients ...

In this video interview, Umesh Chaudhari, executive medical director and global program head of the C5 programs at Regeneron, ...

ABP-745 Phase II Trial Enrollment: Atom Therapeutics has enrolled the first patient in a global Phase II study of ABP-745, a ...

Interim results from the ongoing Phase IV LOTUS trial showed that Daybue delivered sustained behavioral improvements and ...

Viridian Therapeutics announced that it has completed enrollment for the Phase III REVEAL-1 (NCT06812325) and REVEAL-2 (NCT06625398) trials evaluating VRDN-003 in patients with active and chronic ...

The FDA-approved therapy is now included in National Comprehensive Cancer Network clinical guidelines as a treatment option ...